KARACHI: Pakistan Stock Exchange above the 98,000 mark on Friday as share prices surged more than 2,000 points in intraday trade
WHO stops Hydroxychloroquine trials over safety concerns
GENEVA: The World Health Organization (WHO) has temporarily suspended the clinical trial of Anti-Malarial Drug Hydroxychloroquine, a possible drug to prevent coronavirus.
Tedros Adhanom Ghebreyesus,WHO Director-General told a news conference that the ban was temporary and that all aspects of the drug were being reviewed. The ban was imposed on the recommendation of an organization working on drugs to prevent corona in different countries.
The Lancet, a peer-reviewed medical journal, published a study yesterday which found that the drug could increase the risk of death in Corona patients.
It may be recalled that US President Donald Trump had revealed that he was taking hydroxychloroquine every day for two weeks to ward off the new coronavirus while the Brazilian Minister of Health had also suggested taking this drug.
WHO expert Maria Van Kerkhove also urged all countries to remain on high alert, even those who have had success suppressing the virus.
You May Also Like
TEHRAN: The head of Iran’s Revolutionary Guards described the arrest warrant issued by the International Criminal Court for Israeli Prime
LOWER KURRAM: The death toll in yesterday’s gun attack on passenger vans in Khyber Pakhtunkhwa’s Lower Kurram has risen to 42,
